Notice2023-22465
Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 11, 2023
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 195 (Wednesday, October 11, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 195 (Wednesday, October 11, 2023)]
[Notices]
[Pages 70422-70423]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-22465]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket Nos. FDA-2013-N-0804; FDA-2010-N-0598; FDA-2022-N-0081; FDA-
2022-N-1886; FDA-2022-N-2657; FDA-2023-N-0895; FDA-2023-N-0343; FDA-
2023-N-0134; FDA-2022-N-3208; FDA-2017-N-0084; FDA-2023-N-1168; FDA-
2016-N-2474; FDA-2014-N-0086; FDA-2017-N-0366; FDA-2019-N-3657; FDA-
2023-N-0155; FDA-2010-N-0601; FDA-2023-N-2757]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approvals
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is publishing a list of
information collections that have been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
<a href="/cdn-cgi/l/email-protection#a8f8fae9fbdcc9cecee8ceccc986c0c0db86cfc7de"><span class="__cf_email__" data-cfemail="2b7b796a785f4a4d4d6b4d4f4a05434358054c445d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The following is a list of FDA information
collections recently approved by OMB under section 3507 of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control
number and expiration date of OMB approval for each information
collection are shown in table 1. Copies of the supporting statements
for the information collections are available on the internet at
<a href="https://www.reginfo.gov/public/do/PRAMain">https://www.reginfo.gov/public/do/PRAMain</a>. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
OMB control Date approval
Title of collection No. expires
------------------------------------------------------------------------
Premarket Notification Submission 0910-0120 7/31/2026
510(k), Subpart E......................
Good Manufacturing Practice Regulations 0910-0154 7/31/2026
for Type A Medicated Articles..........
Tradeoff Analysis of Prescription Drug 0910-0917 7/31/2026
Product Claims in Direct-to-Consumer
and Healthcare Provider Promotion......
Endorser Status and Actual Use in Direct- 0910-0918 7/31/2026
to-Consumer Television Ads.............
Assessing Physiological, Neural and Self- 0910-0919 7/31/2026
Reported Response to Tobacco Education
Messages...............................
Imports and Electronic Import Entries... 0910-0046 8/31/2026
Current Good Manufacturing Practices for 0910-0116 8/31/2026
Blood and Related Regulations for and
Blood Components; and Requirements for
Donor Testing, Donor Notification, and
``Lookback''...........................
Administrative Practices and Procedures; 0910-0191 8/31/2026
Formal Hearings........................
Adverse Experience/Events with Approved 0910-0284 8/31/2026
New Animal Drugs.......................
Adverse Event Program for Medical 0910-0471 8/31/2026
Devices (Medical Product Safety Network
(MedSun))..............................
Human Cells, Tissues, and Cellular and 0910-0543 8/31/2026
Tissue-Based Products..................
New Animal Drugs for Minor Use and Minor 0910-0605 8/31/2026
Species................................
Potential Tobacco Product Violations 0910-0716 8/31/2026
Reporting Form.........................
Food and Drug Administration Advisory 0910-0833 8/31/2026
Committee Regulations..................
Accreditation Scheme for Conformity 0910-0889 8/31/2026
Assessment Program.....................
Quantitative Research on Front of 0910-0920 8/31/2026
Package Labeling on Packaged Foods.....
Current Good Manufacturing Practice 0910-0152 9/30/2026
Regulations for Medicated Feed.........
Medical Devices--Voluntary Improvement 0910-0922 9/30/2026
Program................................
------------------------------------------------------------------------
[[Page 70423]]
Dated: October 5, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-22465 Filed 10-10-23; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 11, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.